Enhanced IFN-γ production in vitro by CD8+ T cells in hemophiliacs with AIDS as demonstrated on the single-cell level

Clinical Immunology

Volumn 92, Issue 1, 1999, Pages 111-117

  Pae, Y ^a   Minagawa, H ^a   Hayashi, J ^b   Kashiwagi, S ^b   Yanagi, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

CD28; HIV; IFN ; Intracellular cytokine; Th1 Th2

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; HEMOPHILIA; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERFERON PRODUCTION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0032977571     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4721     Document Type: Article

References (39)

1. Shearer G. M., Clerici M. Early T-helper cell defects in HIV infection. AIDS. 5:1991;245-253.
2. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:1986;2348-2357.
3. Parronchi P., Macchia D., Piccinni M. P., Biswas P., Simonelli C., Maggi E., Ricci M., Ansari A. A., Romagnani S. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. USA. 88:1991;4538-4542.
4. Del Prete G. F., De Carli M., Mastromauro C., Biagiotti R., Macchia D., Falagiani P., Ricci M., Romagnani S. Purified protein derivative of mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88:1991;346-350.
5. Clerici M., Shearer G. M. A TH1-TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today. 14:1993;107-111.
6. Clerici M., Hakim F. T., Venzon D. J., Blatt S., Hendrix C. W., Wynn T. A., Shearer G. M. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:1993;759-765.
7. Barcellini W., Rizzardi G. P., Borghi M. O., Fain C., Lazzarin A., Meroni P. L. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS. 8:1994;757-762.
8. + T-cell clones in human immunodeficiency virus infection. Blood. 84:1994;4262-4268.
9. Clerici M., Wynn T. A., Berzofsky J. A., Blatt S. P., Hendrix C. W., Sher A., Coffman R. L., Shearer G. M. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93:1994;768-775.
10. Meroni L., Trabattoni D., Balotta C., Riva C., Gori A., Moroni M., Louisa Villa M., Clerici M., Galli M. Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection. AIDS. 10:1996;23-30.
11. + T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J. Exp. Med. 180:1994;489-495.
12. Meyaard L., Hovenkamp E., Keet I. P. M., Hooibrink B., de Jong I. H., Otto S. A., Miedema F. Single-cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals: Decreased IFN-γ in the presence of preserved IL-4 production. J. Immunol. 157:1996;2712-2718.
13. Maggi E., Mazzetti M., Ravina A., Annunziato F., De Carli M., Piccinni M. P., Manetti R., Carbonari M., Pesce A. M., Del Prete G., Romagnani S. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and Th0 cells. Science. 265:1994;244-248.
14. Graziosi C., Pantaleo G., Gantt K. R., Fortin J. P., Demarest J. F., Cohen O. J., Sekaly R. P., Fauci A. S. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science. 265:1994;248-252.
15. Klein S. A., Dobmeyer J. M., Dobmeyer T. S., Pape M., Ottmann O. G., Helm E. B., Hoelzer D., Rossol R. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS. 11:1997;1111-1118.
16. Kihara M., Ichikawa S., Kihara M., Yamasaki S. Descriptive epidemiology of HIV/AIDS in Japan, 1985-1994. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14:1997;S3-S12.
17. Yamada K. Pathological status and therapy of HIV-infected hemophiliacs in Japan. Southeast Asian J. Trop. Med. Pub. Health. 23:1992;S127-S130.
18. Andreoni M., Sarmati L., Ercoli L., Nicastri E., Giannini G., Galluzzo C., Pirillo M. F., Vella S. Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy. AIDS Res. Hum. Retroviruses. 13:1997;555-561.
19. Hayashi J., Ohmiya M., Kishihara Y., Tani Y., Kinukawa N., Ikematsu H., Kashiwagi S. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C. Am. J. Gastroenterol. 89:1994;2151-2156.
20. Lanier L. L., Le A. M., Phillips J. H., Warner N. L., Babcock G. F. Subpopulation of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J. Immunol. 131:1983;1789-1796.
21. Solbach W. Tumor-promoting phorbol esters selectively abrogate the expression of the T4 differentiation antigen expressed on normal and malignant (Sezary) T helper lymphocytes. J. Exp. Med. 156:1982;1250-1255.
22. Fuchs D., Hausen A., Reibnegger G., Werner E. R., Werner-Felmayer G., Dierich M. P., Wachter H. Interferon concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. J. Acquir. Immune Defic. Syndr. 2:1989;158-162.
23. Breen E. C., Salazar-Gonzalez J. F., Shen L. P., Kolberg J. A., Urdea M. S., Martinez-Maza O., Fahey J. L. Circulating CD8 T cells show increased interferon-gamma mRNA expression in HIV infection. Cell. Immunol. 178:1997;91-98.
24. Emilie D., Peuchmaur M., Maillot M. C., Crevon M. C., Brousse N., Delfraissy J. F., Dormont J., Galanaud P. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J. Clin. Invest. 86:1990;148-159.
25. Westby M., Marriott J. B., Guckian M., Cookson S., Hay P., Dalgleish A. G. Abnormal intracellular IL-2 and interferon-gamma (IFN-γ) production as HIV-1-associated markers of immune dysfunction. Clin. Exp. Immunol. 111:1998;257-263.
26. Caruso A., Licenziati S., Canaris A. D., Cantalamessa A., Corulli M., Benzoni B., Peroni L., Balsari A., Turano A. Characterization of T cell subsets involved in the production of IFN-γ in asymptomatic HIV-infected patients. AIDS Res. Hum. Retroviruses. 12:1996;135-141.
27. - cell population in the blood and lung of HIV-positive patients. J. Acquir. Immune Defic. Syndr. 6:1993;1194-1204.
28. Borthwick N. J., Bofill M., Gombert W. M., Akber A. N., Medina E., Sagawa K., Lipman M. C., Johnson M. A., Janossy G. Lymphocyte activation in HIV-1 infection. AIDS. 8:1994;431-441.
29. Kammerer R., Iten A., Frei P. C., Burgisser P. Expansion of T cells negative for CD28 expression in HIV infection. Med. Microbiol. Immunol. 185:1996;19-25.
30. Linsley P. S., Brady W., Grosmaire L., Aruffo A., Damle N. K., Ledbetter J. A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:1991;721-730.
31. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177:1993;1791-1796.
32. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS. 10:1996;F17-G22.
33. - T lymphocytes. J. Immunol. 150:1993;1147-1159.
34. - lymphocytes in human immunodeficiency virus-specific cytotoxic activity. J. Virol. 70:1996;2022-2026.
35. + T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin. Immunol. Immunopathol. 69:1993;106-116.
36. + cell response against human immunodeficiency virus: Implications for long-term survival. Proc. Natl. Acad. Sci. USA. 92:1995;11135-11139.
37. + T cells and this effect overrides its ability to stimulate virus expression. Proc. Natl. Acad. Sci. USA. 92:1995;10985-10989.
38. + cell antiviral factor. Cell. Immunol. 153:1994;329-343.
39. Poli G., Biswas P., Fauci A. S. Interferons in the pathogenesis and treatment of human immunodeficiency virus infection. Antiviral Res. 24:1994;221-233.